Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Allergy Asthma Clin Immunol. 2010 Jun 8;6(1):12. doi: 10.1186/1710-1492-6-12.

The clinical utility of molecular diagnostic testing for primary immune deficiency disorders: a case based review.

Author information

  • 1Department of Clinical Immunology Auckland City Hospital, Park Rd, Grafton, Auckland New Zealand. immunology@xtra.co.nz.

Abstract

Primary immune deficiency disorders (PIDs) are a group of diseases associated with a genetic predisposition to recurrent infections, malignancy, autoimmunity and allergy. The molecular basis of many of these disorders has been identified in the last two decades. Most are inherited as single gene defects. Identifying the underlying genetic defect plays a critical role in patient management including diagnosis, family studies, prognostic information, prenatal diagnosis and is useful in defining new diseases. In this review we outline the clinical utility of molecular testing for these disorders using clinical cases referred to Auckland Hospital. It is written from the perspective of a laboratory offering a wide range of tests for a small developed country.

PMID:
20529312
[PubMed]
PMCID:
PMC2903612
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for BioMed Central Icon for PubMed Central
    Loading ...
    Write to the Help Desk